Xwell, Inc.

  • Moat Score
  • Market Cap $6.10M
  • PE -0
  • Debt $NaN
  • Cash $5.12M
  • EV $NaN
  • FCF -$12.06M

Earnings

loading chart...

Sales & Net Margins

loading chart...
Earnings-$14.52M
EBIT-$15.36M
ROE-98%
ROA-45%
FCF-$12.06M
Equity$14.83M
Growth Stability1
PE-0.42
PB0.41
P/FCF-0.51
P/S0.18
Price/Cash0.84
Net Margins-35%
Gross Margins26%
Op. Margins-45%
Sales Growth YoY13%
Sales Growth QoQ-9%
Sales CAGR2%
FCF CAGR-0%
Equity CAGR3%
Earnings Growth YoY-58%
Earnings Growth QoQ138%
Sales CAGR 5Y8%
Equity CAGR 5Y-31%
Earnings CAGR 3Y-36%
Sales CAGR 3Y-36%
Equity CAGR 3Y-52%
Market Cap$6.10M
Revenue$33.83M
Assets$33.79M
Cash$5.12M
Shares Outstanding4.39M
Moat Score1%
Working Capital9.66M
Current Ratio1.98
Gross Profit$8.68M
Shares Growth 3y-5%
Equity Growth QoQ-14%
Equity Growth YoY-46%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...
XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four brands: XpresCheck, XpresSpa, Treat, and HyperPointe. XpresSpa is an airport retailer of wellness services and related products. Treat is a travel health and wellness brand that offers in-airport spa and wellness medical services. XpresCheck provides Covid-19 screening and diagnostic testing in partnership with the CDC. HyperPointe is a digital healthcare and data analytics relationship company.

SEC Filings

Direct access to Xwell, Inc. (XWEL) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

  • 2024
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2023
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2022
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31

Sector Comparison

How does Xwell, Inc. compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Xwell, Inc. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

loading chart...

Xwell, Inc. Discounted Cash Flow

Fully customizable DCF calculator online for Xwell, Inc..

= -$119M
012345678910TV
fcf-$12M-$12M-$12M-$12M-$12M-$12M-$12M-$12M-$12M-$12M-$12M-$119M
DCF-$11M-$9.9M-$9M-$8.2M-$7.4M-$6.7M-$6.1M-$5.6M-$5M-$4.6M-$46M
Value-$119M

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years12/201412/201512/201612/201712/201812/201912/202012/202112/202212/2023TTM
Net Margins-8K%-50%-127%-59%-74%-44%-1K%4%-59%-93%-35%
ROA--19%-27%-23%-114%-55%-39%3%-44%-72%-45%
ROE--28%-37%-63%-283%837%-115%3%-68%-134%-98%

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years12/201412/201512/201612/201712/201812/201912/202012/202112/202212/2023TTM
Debt over FCF--1.24-0.72-0.49-1.56-2.41-0.20.35---
Debt over Equity00.080.10.141.14-2.270.070.04---
Growth Stability----------1

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years12/201412/201512/201612/201712/201812/201912/202012/202112/202212/2023CAGR 5Y
Revenue YoY growth-1K%-16%157%3%-3%-83%779%-24%-46%8%
Earnings YoY growth--90%113%20%29%-43%335%-103%-1K%-15%-
Equity YoY growth-30%58%-29%-71%-119%-3K%24%-52%-56%-31%
FCF YoY growth--91%253%46%-28%-75%1K%-135%-398%-41%-